산우웨이헬스(SNWV) 주가 전망 및 기업 분석 - PER·배당·실적·목표주가·RSI·MACD

Q: What kind of company is 산우웨이헬스(SNWV)?

산우웨이헬스(SNWV) belongs to the Healthcare sector and operates in the Medical Devices industry.

Q: What is the market cap of SNWV?

The market cap of SNWV is approximately $52M, ranking 4,893 within its sector.

Q: What is the P/E ratio of SNWV?

SNWV has a P/E ratio of approximately 18.7x, which can be used to assess its valuation relative to the Healthcare sector average.

Q: What is the 52-week high and low for SNWV?

SNWV has recorded a 52-week high of $46.58 and a low of $5.77.

SNWV

Sanuwave Health Inc

7월 27일 4:00 PM ET (한국 7/28 05:00)

$6.10

+0.17 ▲ +2.87%

🌙 7월 28일 6:13 AM ET (한국 7/28 19:13)

$6.12

+0.02 ▲ +0.33%

산우웨이헬스(SNWV) is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.

시가총액

$52M

스몰캡

P/E

18.7

적정 수준

배당수익률

없음

52주 위치

저점 +6% · 고점 -87%

애널리스트

적극 매수

B-

Fundamental health

vs. Medical Devices 초소형주

수익성

Top 3%

성장

Top 44%

밸류에이션

Top 55%

재무 안정

Top 77%

Index ⓘ	-	P/E ⓘ	18.66	EPS (ttm) ⓘ	0.33	Insider Own ⓘ	5.42%	Shs Outstand ⓘ	8.6M	Perf Week ⓘ	-4.69%
Market Cap ⓘ	0.05B	Forward P/E ⓘ	-	EPS next Y ⓘ	-	Insider Trans ⓘ	-20.84%	Shs Float ⓘ	8.1M	Perf Month ⓘ	-20.05%
Enterprise Value ⓘ	0.06B	PEG ⓘ	-	EPS next Q ⓘ	-	Inst Own ⓘ	57.61%	Short Float ⓘ	7.57%	Perf Quarter ⓘ	-67.38%
Income ⓘ	0.02B	P/S ⓘ	1.18	EPS this Y ⓘ	-	Inst Trans ⓘ	3%	Short Ratio ⓘ	2.96	Perf Half Y ⓘ	-77.06%
Sales ⓘ	0.04B	P/B ⓘ	28.52	EPS next 5Y ⓘ	-	ROA ⓘ	47.24%	Short Interest ⓘ	0.62M	Perf YTD ⓘ	-79.56%
Book/sh ⓘ	0.21	P/C ⓘ	4.87	EPS past 3/5Y ⓘ	-	ROE ⓘ	-	52W High ⓘ	-86.91% ($46.58)	Perf Year ⓘ	-83.89%
Cash/sh ⓘ	1.25	P/FCF ⓘ	13.38	Sales past 3/5Y ⓘ	38.05% 61.12%	ROIC ⓘ	88.59%	52W Low ⓘ	5.72% ($5.77)	Perf 3Y ⓘ	-6.78%
Dividend Est. ⓘ	-	EV/EBITDA ⓘ	15.34	EPS Y/Y TTM ⓘ	128.52%	Gross Margin ⓘ	74.63%	Volatility(W/M) ⓘ	8.15% 12.73%	Perf 5Y ⓘ	-88.78%
Dividend TTM ⓘ	-	EV/Sales ⓘ	1.44	Sales Y/Y TTM ⓘ	22.49%	Oper. Margin ⓘ	6.4%	ATR (14) ⓘ	1.05	Perf 10Y ⓘ	-77.41%
Dividend Ex-Date ⓘ	-	Quick Ratio ⓘ	0.99	EPS Q/Q ⓘ	74.77%	Profit Margin ⓘ	36.21%	RSI (14) ⓘ	31.35	Recom ⓘ	1
Dividend Gr. 3/5Y ⓘ	-	Current Ratio ⓘ	1.31	Sales Q/Q ⓘ	2.97%	SMA20 ⓘ	-30.75% ($8.81)	Beta ⓘ	1.51	Target Price ⓘ	$40
Payout ⓘ	-	Debt/Eq ⓘ	12.04	Earnings ⓘ	2026/5/12	SMA50 ⓘ	-48.57% ($11.86)	Rel Volume ⓘ	0.53	Prev Close ⓘ	$5.93
Employees ⓘ	55	LT Debt/Eq ⓘ	8.85	EPS/Sales Surpr. ⓘ	-21.43% 0.2%	SMA200 ⓘ	-72.84% ($22.46)	Avg Volume(3M) ⓘ	0.21M	Price ⓘ	$6.1
IPO ⓘ	2009/9/30	Option/Short ⓘ	No/Yes			Trades ⓘ	1159	Volume ⓘ	111,032	Change ⓘ	2.87%

Quarterly earnings trend SEC filings · USD

24.6

24.9

24.12*

25.3

25.6

25.9

25.12*

26.3

Revenue Net income 최근 분기: 매출 $10M (YoY +4%) · 순이익 $-1M (YoY +76%)

* Q4 figures are derived from the annual filing (10-K) · loss-making quarters are underlined in red

📊 Sanuwave Health Inc (SNWV) Investment Analysis

What kind of company is Sanuwave Health Inc?

산우웨이헬스(SNWV) 초고성장주

Healthcare · Medical Devices

Small-Cap — Low Volume, High Volatility

🩹 SanuWave Health (SNWV) is a U.S. medical device company focused on wound care and regenerative medicine. It develops and supplies treatment solutions targeting chronic wounds and tissue regeneration, and is a small healthcare company with hospitals and specialized wound care facilities as its primary customers.

Learn more about Sanuwave Health Inc →

Market Cap

$0.1B

Approx. KRW 0.1 trillion

⚖️ 0% of Samsung Electronics

Market Cap Rank4893

Employees55people

IPO2009/09/30

Current Price$6.10 ≈ 8,357원

NASD · USA

Key Events

⏰ Upcoming events

🔔 Earnings release

The next release date has not been announced yet.

🎯 Ex-dividend date

No scheduled dividends

📜 Recent events

🔔 Earnings release 2026년 5월 13일 (수) · 장 시작 전

🔔 Earnings release 2026년 5월 12일 (화) · 장 마감 후 EPS -21.4% 매출 +0.2%

🔔 Earnings release 2026년 3월 26일 (목) · 장 마감 후 EPS +411.8% 매출 +1.1%

Is it profitable?

Profitable but financially weak

High debt load may weigh on results in a downturn

Profitability — How efficiently it makes money

Operating Margin

Profit kept from selling products and services (higher is better)

6.4%

✓ 우수

My positionTop 5%

Low range Average High range

Medical Devices 초소형주 Median -83.5% · Top tier

💡 일반적으로 10% 이상이면 양호, 20% 이상이면 우수

Net Margin

Share of revenue left after taxes and interest are paid

36.2%

✓ 우수

My positionTop 5%

Low range Average High range

Medical Devices 초소형주 Median -96.5% · Top tier

💡 일반적으로 8% 이상이면 양호, 15% 이상이면 우수

Gross Margin

Profit after subtracting raw-material costs only (signals product competitiveness)

74.6%

✓ 우수

My positionTop 25%

Low range Average High range

Medical Devices 초소형주 Median 44.2% · Top 16%

💡 제조업 30%, IT/소프트웨어 50% 이상이면 우수 (업종별 편차 큼)

ROA

Annual earnings relative to total company assets

47.2%

✓ 우수

My positionTop 5%

Low range Average High range

Healthcare 초소형주 Median -59.3% · Top tier

💡 일반적으로 5% 이상이면 양호, 10% 이상이면 우수

ROIC

Return generated per dollar invested in the business

88.6%

✓ 우수

My positionTop 5%

Low range Average High range

Healthcare 초소형주 Median -77.3% · Top tier

💡 자본비용(보통 8~10%)보다 높으면 가치 창출, 15% 이상이면 우수

Financial health — Debt & liquidity burden

Debt-to-Equity (D/E)

Debt relative to equity (lower is healthier)

12.04

✓ Danger level

💡 일반적으로 1.0 이하면 건전, 1.5까지는 무난 (금융·유틸·REIT는 구조적으로 높음)

Current Ratio

Liquid assets available to cover liabilities due within a year

1.31

✓ 평균

My positionMid-range

Low range Average High range

Medical Devices Median 2.91

💡 1.5~3.0 적정, 1.0 미만이면 단기 유동성 주의

Quick Ratio

Liquid assets excluding inventory, available for immediate use

0.99

✓ 평균

My positionMid-range

Low range Average High range

Medical Devices Median 2.09

💡 1.0 이상이면 안전, 0.5 미만이면 주의

* Ratings reflect relative position vs. peer-group distribution (same sector & size) plus absolute guards (loss & risk thresholds).

What's the outlook?

Mixed Outlook

Positive and negative signals are mixed

애널리스트 목표가

$40.00

현재가 대비 +555.7%

💡 12개월 이내 도달을 전망하는 애널리스트 컨센서스 평균

⚠ 이 데이터는 애널리스트 추정치이며 실제 결과와 다를 수 있습니다. 투자 결정은 추가 검토와 함께 하세요.

Did earnings meet expectations?

High Earnings Volatility

Frequently misses analyst estimates

예상 상회

예상 부합

예상 하회

상회 비율

-51.9%

평균 서프라이즈

2026.05.12

하회

-21.4%

2026.03.26

하회

실적 $0.03 · 예상 $0.17 -82.4%

💡 예상보다 높은 실적을 자주 내는 기업은 실적 신뢰도가 높다고 평가됩니다. 단, 애널리스트 기대치가 낮게 설정되었을 수도 있으니 절대 수치도 함께 봐야 합니다.

Is it growing?

Average Growth

Mid-range within the industry

📊 How much has it grown? (actual results)

Past 5-Year Revenue

How much revenue grew over the past 5 years

+61.1%

양호

My positionMid-range

Low range Average High range

초고성장주 초소형주 Median 47.0% · Top 37%

⚡ Short-term momentum

QoQ Revenue

Revenue change from the previous quarter (short-term momentum)

+3.0%

평균

My positionMid-range

Low range Average High range

초고성장주 초소형주 Median 3.6% · Bottom 50%

* Forecast values are analyst consensus estimates. Ratings are determined by relative position vs. peer group of the same growth style and size.

New to investing terms? Look it up in the financial dictionary →

Has the stock risen over the long term?

Long-term weakness — -157%p below the market

SNWV -88.8% · S&P 500 +68.3%

Excess return vs. market (price-based, ex-dividends)

5-year basis

vs S&P 500

-157.1%p

Significantly behind the market

vs Health Care (XLV)

-113.3%p

Significantly behind the sector average

1-year basis

vs S&P 500

-99.9%p

Significantly behind the market

vs Health Care (XLV)

-103.6%p

Significantly behind the sector average

Rank among peers

5-year return Upper-Mid (39%) Based on 56 peers

1-year return Bottom 25% Based on 68 peers

Current position within 52-week range

Low (-5.7%p) High (-86.9%p)

Current price is 5.7% above the 52-week low and 86.9% below the 52-week high

Recent risk (last 120 trading days)

Max drawdown

-77.1%

Annualized volatility

131.0%

Technical Indicators

Bollinger Bands · MACD · RSI · Stochastics · Ichimoku 5-line · recent 136-day series

Price · Bollinger Bands · Ichimoku Cloud

close
BB Upper
BB Mid
BB Lower
Tenkan
Kijun
Cloud (SpanA/B)

Bollinger Bands are upper and lower channels showing the closing price range (20 days · 2σ). Touching the upper band = overheated; touching the lower band = oversold. Ichimoku Cloud shows trend direction and strength through colored areas. Prices above the cloud indicate an uptrend; prices below indicate a downtrend. About Bollinger Bands →

🔴

Current diagnosis · 2026-07-27

Downtrend zone

Current price $6.10 below the midline ($8.81). Normal downward flow. Below the Ichimoku cloud (bearish).

MACD (12 · 26 · 9) Expand ▼

An indicator that uses the difference between the short-term EMA (12) and long-term EMA (26) to identify trend reversals. When MACD rises above the Signal line, it is a buy signal (golden cross); when it falls below, it is a sell signal (death cross). About MACD →

🔴

Current diagnosis · 2026-07-27

Bearish momentum holding

MACD -1.689 < Signal -1.509 in negative zone + Hist negative (-0.181). Weakness in progress.

RSI(14) · Stochastics %K(14) Expand ▼

RSI measures short-term buying and selling pressure on a scale of 0–100. 30 or below = oversold (a rebound may be possible); 70 or above = overbought (a pullback may be possible). Stoch %K similarly measures short-term momentum strength. RSI · Learn more about Stochastics →

🔴

Current diagnosis · 2026-07-27

Bearish zone

RSI 31.3 (below the neutral level of 50). Selling pressure leads, indicating a weak trend. Stoch %K is also 4.6.

※ "Current diagnosis" is an automated interpretation based on standard thresholds and is for reference only. Make your own comprehensive judgment before trading.

Is it attractive at this price?

Cheaper than peers in its industry

Cheap on Vs. Earnings·Vs. Sales·Vs. Cash Flow, Pricey on Vs. Assets

💡 How to read this — Compare against peers in the same industry to see what the price is cheap or expensive relative to. Example: cheap vs. earnings = stock price is low relative to what the company earns; expensive vs. assets = stock price is high relative to assets on the balance sheet.

💵 Vs. Earnings Cheap

🏢 Vs. Assets Pricey

🧾 Vs. Sales Cheap

💧 Vs. Cash Flow Cheap

💵 Vs. Earnings

PER Price-to-Earnings Ratio

How expensive the price is vs. earnings — lower is cheaper

18.66x

✓ Very cheap

My positionTop 25%

Low range Average High range

Medical Devices median 30.60x · Top 15% — relatively cheap within the industry

💡 PER 15 이하 저평가, 25 이상이면 성장성 검증 필요 (적자 기업은 의미 없음)

🏢 Vs. Assets

PBR Price-to-Book Ratio

Price vs. the company's asset value — below 1 trades cheaper than assets

28.52x

✓ Very pricey

My positionBottom 5%

Low range Average High range

Medical Devices 초소형주 median 1.15x · Bottom 1% — expensive within the industry

💡 PBR 1 미만이면 청산가치 이하 (금융·제조업에서 특히 의미, IT는 낮은 비중)

🧾 Vs. Sales

PSR Price-to-Sales Ratio

Market cap vs. revenue — lower is cheaper relative to sales

1.18x

✓ Cheap

My positionMid-range

Low range Average High range

Medical Devices 초소형주 median 1.65x · Around the industry average

💡 PSR 2 이하 저평가, 10 초과면 고평가 (고성장 기업일 때만 정당화)

💧 Vs. Cash Flow

EV/EBITDA Enterprise Value Multiple

Total enterprise value ÷ operating cash earnings — a benchmark for M&A

15.34x

✓ Fair

My positionMid-range

Low range Average High range

Medical Devices median 14.42x · Around the industry average

💡 EV/EBITDA 10 이하 저평가, 20 이상이면 고평가 (M&A 밸류 기준)

💧 Vs. Cash Flow

P/FCF Price-to-Free-Cash-Flow Ratio

Price vs. actual cash generation — lower means more efficient

13.38x

✓ Very cheap

My positionTop 25%

Low range Average High range

Medical Devices median 21.45x · Top 21% — relatively cheap within the industry

💡 P/FCF 20 이하면 현금창출 대비 저평가 (실질 수익성 기준)

Analyst target price (reference)

$40.00 vs. current price +555.7%

* Valuation is the stock's relative position within the industry peer group (same sector and market-cap range). Even when valuation looks attractive, check the 'Profitability' and 'Growth' sections too.

As of: Recent snapshot · Peer group: Medical Devices

Who owns it?

Ownership is broadly stable

Insider net selling -20.8% · Institutional net buying +3.0% · Short interest moderate 7.6%

📈 Recent trading flow (6 months)

🧑‍💼 Insiders (executives & directors)

-20.8%

Insiders large net selling

🏦 Institutions (funds & investors)

+3.0%

Institutions net buying

💡 Net change over the past 6 months. Shows how much insiders and institutions increased or reduced their holdings, in %.

👥 Holdings composition

🏦 Institutions 57.6%

Adequate institutional weight

Healthcare 초소형주 Median 14.2%

🧑‍💼 Insiders 5.4%

Meaningful insider stake

Healthcare 초소형주 Median 16.1%

👤 Retail investors (estimated) 37.0%

Everyone excluding institutions and insiders

Institutions Insiders Retail (est.)

📉 Short-selling metrics

Short ratio

7.6%

Moderate

Healthcare 초소형주 Median 3.9%

Past 90 days Little change

Short interest days to cover

3.0 days

Days needed to close short positions using average trading volume

🧮 Share count

Total shares outstanding 8.6M주

Float (tradable shares) 8.1M주

* Insider/institutional flows are based on net changes over the past 6 months. Trend is cumulative over the past 90 days.

ETFs holding SNWV

ETFs with the highest weightings · 10 total shown

IWC

iShares Micro-Cap ETF

0.03%

$1.4B

GSSC

Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF

0.02%

$1.0B

OMFS

Invesco Russell 2000 Dynamic Multifactor ETF

0.02%

$281M

IWO

iShares Russell 2000 Growth ETF

0.01%

$14.3B

ITWO

ProShares Russell 2000 High Income ETF

0.01%

$197M

* Based on official quarterly filings. Latest disclosure; actual current weights may differ.

How much does it pay in dividends?

This company does not pay a dividend

It may be a growth-focused firm reinvesting profits into expansion. Consider this growth-stock profile when investing.

Compare Industry Peers

💡 vs. sector average ▲ Favorable / ▼ Unfavorable (Lower PER and PBR are better; higher ROE and dividend yield are better)

Sorted by market cap, largest first

Stock	Market Cap	PER	PBR	ROE	Dividend Yield	Change
SNWV This Stock	$52.5M	18.7 ▲	28.5 ▼	-	-	+2.9%
LLY	$1.13T	43.1 ▼	36.2 ▼	107.64% ▲	0.58% ▼	+0.1%
JNJ	$640.9B	30.8 ▼	7.5 ▼	25.74% ▲	2.02% ▲	+1.0%
ABBV	$453.9B	126.7 ▼	-	15221.82% ▲	2.67% ▲	-0.9%
UNH	$379.3B	26.9 ▼	3.9 ▼	12.49% ▲	2.16% ▲	-0.7%
MRK	$323.0B	36.8 ▼	7.0 ▼	18.97% ▲	2.5% ▲	-0.2%
Sector Avg	-	26.1	2.7	-48.83%	1.23%	-

FAQ

What kind of company is 산우웨이헬스(SNWV)?

산우웨이헬스(SNWV) belongs to the Healthcare sector and operates in the Medical Devices industry.

What is the market cap of SNWV?

The market cap of SNWV is approximately $52M, ranking 4,893 within its sector.

What is the P/E ratio of SNWV?

SNWV has a P/E ratio of approximately 18.7x, which can be used to assess its valuation relative to the Healthcare sector average.

What is the 52-week high and low for SNWV?

SNWV has recorded a 52-week high of $46.58 and a low of $5.77.

면책조항: 본 콘텐츠는 참고 자료이며 투자 권유가 아닙니다. 모든 투자의 책임은 투자자 본인에게 있습니다.